Search Results

Return to List
Results 21–39 of 39
Sort By: Relevance | Date | Title
21.

Nonobstetric Surgery During Pregnancy

Committee Opinion Number 474, February 2011

(Replaces No. 284, August 2003, Reaffirmed 2015)

ABSTRACT The American College of Obstetricians and Gynecologists Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for physicians who care for women It is important for a physician to obtain an obstetric consultation before...

February 2011

PDF Format
22.

OnabotulinumtoxinA and the Bladder

Committee Opinion Number 604, June 2014

ABSTRACT In January 2013 the US Food and Drug Administration approved the use of onabotulinumtoxinA also known as Botox A for the treatment of overactive bladder thus providing another treatment option for women Symptoms of overactive bladder have been shown to significantly improve after onabotul...

June 2014

PDF Format
23.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Committee Opinion Number 606, August 2014

(Reaffirmed 2016)

ABSTRACT Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding emerg...

August 2014

PDF Format
24.

Ovarian Reserve Testing

Committee Opinion Number 618, January 2015

ABSTRACT The main goal of ovarian reserve testing is to identify those individuals who are at risk of decreased or diminished ovarian reserve commonly known as DOR Although ovarian reserve testing cannot predict the end of ones reproductive years results outside the range expected for a patients a...

January 2015

PDF Format
25.

Over-the-Counter Access to Oral Contraceptives

Committee Opinion Number 544, December 2012

(Reaffirmed 2016)

ABSTRACT Unintended pregnancy remains a major public health problem in the United States Access and cost issues are common reasons why women either do not use contraception or have gaps in use A potential way to improve contraceptive access and use and possibly decrease unintended pregnancy rates ...

December 2012

PDF Format
26.

Pain Relief During Labor

Committee Opinion Number 295, July 2004

(Replaces No. 231, February 2000, Reaffirmed 2015)

ABSTRACT Pain management should be provided whenever medically indicated The American Society of Anesthesiologists ASA and the American College of Obstetricians and Gynecologists ACOG believe that women requesting epidural analgesia during labor should not be deprived of this service based on thei...

July 2004

PDF Format
27.

Pharmacogenetics

Committee Opinion Number 488, May 2011

(Reaffirmed 2015)

ABSTRACT Pharmacogenetics is the study of genetic variations in drug response that are determined by specific genes It is hoped that the use of pharmacogenetics in clinical practice may improve drug safety and decrease the rate of adverse drug reactions Given the potential applications of pharmaco...

May 2011

PDF Format
28.

Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism

Committee Opinion Number 556, April 2013

(Reaffirmed 2015)

ABSTRACT The development of menopausal symptoms and related disorders which lead women to seek prescriptions for postmenopausal estrogen therapy and hormone therapy is a common reason for a patient to visit her gynecologist but these therapies are associated with an increased risk of venous thromb...

April 2013

PDF Format
29.

Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus

Committee Opinion Number 595, May 2014

Abstract Preexposure prophylaxis is defined as the administration of antiretroviral medications to individuals who are not infected with human immunodeficiency virus HIV and are at the highest risk of acquiring HIV infection In combination with other proven HIVprevention methods preexposure prophy...

May 2014

PDF Format
30.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Committee Opinion Number 485, April 2011

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
31.

Primary Ovarian Insufficiency in Adolescents and Young Women

Committee Opinion Number 605, July 2014

(Reaffirmed 2016)

ABSTRACT Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years There is no consensus on criteria to identify primary ovarian insufficiency in adolescents and delay in diagnosis is common Health care providers who make this c...

July 2014

PDF Format
32.

Professional Relationships With Industry

Committee Opinion Number 541, November 2012

(Replaces No. 401, March 2008, Reaffirmed 2015)

ABSTRACT The American College of Obstetricians and Gynecologists the College has a long history of leadership in ensuring that its educational mission is evidence based and unbiased A predecessor to this Committee Opinion was published in 1985 making the College one of the first professional assoc...

November 2012

PDF Format
33.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Committee Opinion Number 540, November 2012

(Reaffirmed 2016)

ABSTRACT Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones and some data have suggested that use of drospirenonecontaining pills has a higher risk of venous thromboembolism this risk is still ...

November 2012

PDF Format
34.

Solutions for Surgical Preparation of the Vagina

Committee Opinion Number 571, September 2013

(Reaffirmed 2015)

ABSTRACT Currently only povidoneiodine preparations are approved for vaginal surgicalsite antisepsis However there are compelling reasons to consider chlorhexidine gluconate solutions for offlabel use in surgical preparation of the vagina especially in women with allergies to iodine Although chlor...

September 2013

PDF Format
35.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Committee Opinion Number 494, June 2011

(Reaffirmed 2015)

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format
36.

Tamoxifen and Uterine Cancer

Committee Opinion Number 601, June 2014

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT Tamoxifen a nonsteroidal antiestrogen agent is widely used as adjunctive therapy for women with breast cancer and it has been approved by the US Food and Drug Administration for adjuvant treatment of breast cancer treatment of metastatic breast cancer and reduction in breast cancer incide...

June 2014

PDF Format
37.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Committee Opinion Number 659, March 2016

ABSTRACT Cancer treatment should address femalespecific survivorship issues including the hypoestrogenicrelated adverse effects of cancer therapies or of natural menopause in survivors Systemic and vaginal estrogen are widely used for symptomatic relief of vasomotor symptoms sexual dysfunction and...

March 2016

PDF Format
38.

Update on Immunization and Pregnancy Tetanus Diphtheria and Pertussis Vaccination

Committee Opinion Number 566, June 2013

(Replaces No. 521, March 2012, Reaffirmed 2015)

ABSTRACT In the face of dramatic and persistent increases in pertussis disease in the United States the Centers for Disease Control and Preventions Advisory Committee on Immunization Practices has updated its guidelines for the use of the tetanus toxoid reduced diphtheria toxoid and acellular pert...

June 2013

PDF Format
39.

Vitamin D: Screening and Supplementation During Pregnancy

Committee Opinion Number 495, July 2011

(Reaffirmed 2015)

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998